CIQUS scientists in collaboration with UCM researchers synthesize the first fully substituted peptide-fullerene adduct for the selective binding with a receptor involved in cancer. The work have now b...
Read moreResearchers at IRB Barcelona link autophagy (a natural mechanism for renewing cellular components) with the correct development of brown adipose cells.
Read moreMadrid Genotype Score, allows the classification of patients according to the likelihood that their disease has an origin in a heritable genetic mutation
Read moreWork carried out by CBGP researchers of the Scientific Area ‘Synthetic Biology and Bioengineering’, together with the Instituto de Investigación Sanitaria-Fundación Jiménez Díaz, Madrid, has s...
Read moreAutism is a disorder notable for developmental deficits affecting socialisation, communication, imagination and behaviour. In Europe, it affects 1 in 100 children and its causes are still unknown. It ...
Read moreOncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases, today announced the official launch of the OncoDEEP Kit during the ESMO ...
Read moreUn estudio en el que participan investigadores de la Universidad Politécnica de Madrid detecta avances relevantes en pacientes con fibrosis quística incluidos en un programa de entrenamiento de fuer...
Read morea study led by Jordi Alcaraz, lecturer at the Faculty of Medicine and Health Sciences of the UB and researcher at the Institute for Bioengineering of Catalonia (IBEC), has determined that this protein...
Read moreInvestigadores del Cima Universidad de Navarra han identificado nuevos mecanismos implicados en el desarrollo del colangiocarcinoma. El estudio abre nuevas vías terapéuticas para los pacientes con e...
Read moreLa Dra. Ana Oaknin, jefa del Programa de Tumores Ginecológicos del Hospital Vall d'Hebron y jefa del Grupo de Neoplasias Ginecológicas del VHIO, ha dirigido ambos estudios cuyos principales resultad...
Read moreEl estudio KEYNOTE-048 demostró el beneficio del uso de pembrolizumab en los pacientes con un Combined Positive Score (CPS) igual o mayor a 1, que supone entre el 80 y el 85% de todos los pacientes. ...
Read moreUn equipo de investigación del Instituto de la Grasa (CSIC) ha propuesto una técnica biológica, más económica y rápida, como alternativa para la gestión tradicional de los residuos procedentes ...
Read more